Suppr超能文献

院内心搏骤停后目标温度管理:心脏骤停伴非可除颤节律试验数据的目标温度管理辅助分析。

Targeted Temperature Management After In-Hospital Cardiac Arrest: An Ancillary Analysis of Targeted Temperature Management for Cardiac Arrest With Nonshockable Rhythm Trial Data.

机构信息

Médecine Intensive Réanimation, University Hospital Center, Nantes, France.

Medical-Surgical Intensive Care Unit, District Hospital Center, La Roche-sur-Yon, France.

出版信息

Chest. 2022 Aug;162(2):356-366. doi: 10.1016/j.chest.2022.02.056. Epub 2022 Mar 19.

Abstract

BACKGROUND

Targeted temperature management (TTM) currently is the only treatment with demonstrated efficacy in attenuating the harmful effects on the brain of ischemia-reperfusion injury after cardiac arrest. However, whether TTM is beneficial in the subset of patients with in-hospital cardiac arrest (IHCA) remains unclear.

RESEARCH QUESTION

Is TTM at 33 °C associated with better neurological outcomes after IHCA in a nonshockable rhythm compared with targeted normothermia (TN; 37 °C)?

STUDY DESIGN AND METHODS

We performed a post hoc analysis of data from the published Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm randomized controlled trial in 584 patients. We included the 159 patients with IHCA; 73 were randomized to 33 °C treatment and 86 were randomized to 37 °C treatment. The primary outcome was survival with a good neurologic outcome (cerebral performance category [CPC] score of 1 or 2) on day 90. Mixed multivariate adjusted logistic regression analysis was performed to determine whether survival with CPC score of 1 or 2 on day 90 was associated with type of temperature management after adjustment on baseline characteristics not balanced by randomization.

RESULTS

Compared with TN for 48 h, hypothermia at 33 °C for 24 h was associated with a higher percentage of patients who were alive with good neurologic outcomes on day 90 (16.4% vs 5.8%; P = .03). Day 90 mortality was not significantly different between the two groups (68.5% vs 76.7%; P = .24). By mixed multivariate analysis adjusted by Cardiac Arrest Hospital Prognosis score and circulatory shock status, hypothermia was associated significantly with good day 90 neurologic outcomes (OR, 2.40 [95% CI, 1.17-13.03]; P = .03).

INTERPRETATION

Hypothermia at 33 °C was associated with better day 90 neurologic outcomes after IHCA in a nonshockable rhythm compared with TN. However, the limited sample size resulted in wide CIs. Further studies of patients after cardiac arrest resulting from any cause, including IHCA, are needed.

摘要

背景

目标温度管理(TTM)目前是唯一被证明能减轻心脏骤停后缺血再灌注损伤对大脑有害影响的治疗方法。然而,在院内心脏骤停(IHCA)患者亚组中,TTM 是否有益仍不清楚。

研究问题

与目标正常体温(TN;37°C)相比,33°C 的 TTM 是否与非可电击节律的 IHCA 后更好的神经结局相关?

研究设计和方法

我们对已发表的非可电击节律心脏骤停的目标温度管理试验中的数据进行了事后分析,该试验纳入了 584 名患者。我们纳入了 159 名 IHCA 患者;73 名患者被随机分配到 33°C 治疗组,86 名患者被随机分配到 37°C 治疗组。主要结局是 90 天时存活且神经功能良好(脑功能分类[CPC]评分 1 或 2)。采用混合多变量调整逻辑回归分析,确定在调整基线特征后,90 天时 CPC 评分 1 或 2 的存活是否与温度管理类型相关,这些特征未通过随机分配达到平衡。

结果

与 48 小时 TN 相比,24 小时 33°C 低温与 90 天时存活且神经功能良好的患者比例更高(16.4%比 5.8%;P=.03)。两组之间第 90 天死亡率无显著差异(68.5%比 76.7%;P=.24)。通过按心脏骤停医院预后评分和循环休克状态调整的混合多变量分析,低温与 90 天的良好神经结局显著相关(OR,2.40[95%CI,1.17-13.03];P=.03)。

解释

与 TN 相比,非可电击节律的 IHCA 患者中,33°C 的低温与 90 天时更好的神经结局相关。然而,由于样本量有限,置信区间较宽。需要进一步研究任何原因导致的心脏骤停后患者,包括 IHCA。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验